Bristol-Myers Squibb

Top High-Dividend Healthcare Stocks
Seeking Alpha
Thu, 09/22/11 - 02:20 pm
dividends
Abbott Laboratories
AstraZeneca
Bristol-Myers Squibb
GSK
JNJ
Eli Lilly
Merck
Novartis
Pfizer
Sanofi
Why Bristol-Myers Squibb's Earnings Are Outstanding
Motley Fool
Thu, 09/22/11 - 11:12 am
earnings
Bristol-Myers Squibb
Why Bristol-Myers Squibb Could Be Acquired by Lilly or Bayer
BNET Pharma
Wed, 09/21/11 - 12:36 pm
Lilly
Bayer
Bristol-Myers Squibb
M&A
5 Reasons To Buy Bristol-Myers Squibb
Seeking Alpha
Tue, 09/20/11 - 10:31 am
Bristol-Myers Squibb
Why Merck May Be About to Take Off
Motley Fool
Mon, 09/19/11 - 12:08 pm
Merck
Abbott Laboratories
Bristol-Myers Squibb
Allergan
Bristol-Myers Pegged as Takeover Target
WSJ Online
Mon, 09/19/11 - 12:05 pm
M&A
Bristol-Myers Squibb
Pfizer
BMS-790052 Plus Peginterferon Alfa and Ribavirin Demonstrated up to 83% Sustained Virologic Response 24 Weeks Post-Treatment (SVR24) in Phase II Study of Genotype 1 Hepatitis C Patients
Yahoo/BusinessWire
Sun, 09/18/11 - 12:14 pm
Bristol-Myers Squibb
BMS-790052
Peginterferon Alfa
Ribavirin
hepatitis C
10 Hep C Stocks on Wall Street's Watch List
TheStreet.com
Thu, 09/15/11 - 11:58 am
hepatitis C
Vertex
Merck
Anadyx
Pharmasset
Gilead
Bristol-Myers Squibb
JNJ
Medivir
Achillion
Inhibitex
Indenix
6 Deeply Undervalued Biotech Companies
Seeking Alpha
Wed, 09/14/11 - 11:03 am
Amgen
Biogen Idec
Bristol-Myers Squibb
Dendreon
Gilead
GSK
Oncothyreon
JNJ
Novartis
Sanofi
UBS
Vanda
Abbott Laboratories is Dealing to Flank Other Drug Makers
Yahoo/Wall St. Cheat Sheet
Wed, 09/14/11 - 10:19 am
Abbott Laboratories
Amgen
Bristol-Myers Squibb
Bristol-Myers Takes Over Amira Pharma
Yahoo/Zacks.com
Mon, 09/12/11 - 05:36 pm
Amira
Bristol-Myers Squibb
M&A
Sanofi
Bristol-Meyers Squibb: Can This High-Yielding Healthcare Stock Sustain Its Dividend?
Seeking Alpha
Mon, 09/12/11 - 09:56 am
Bristol-Myers Squibb
dividends
Anti-Clotting Stumble For J&J/Bayer Likely to Help Pfizer/Bristol-Meyers
Seeking Alpha
Fri, 09/9/11 - 11:36 am
JNJ
Bayer
Pfizer
Bristol-Myers Squibb
Xarelto
Harvard Scientists Discover How Cancer Outwits Erbitux Drug
Bloomberg
Thu, 09/8/11 - 11:15 am
Erbitux
Eli Lilly
breast cancer
Bristol-Myers Squibb
7 High-Yield Large-Cap Pharmas: Recent Performance And Yield Review
Seeking Alpha
Wed, 08/31/11 - 12:52 pm
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
GSK
Merck
Sanofi
Pfizer
Time To Take A Second Look At Big Pharma
Seeking Alpha
Mon, 08/29/11 - 05:44 pm
Abbott Laboratories
Bristol-Myers Squibb
Merck
Eli Lilly
Pfizer
Analyst Says Xarelto Niche "Still Secure"
Forbes
Mon, 08/29/11 - 10:57 am
Xarelto
bloodthinners
Bayer
JNJ
Pfizer
Bristol-Myers Squibb
Eliquis
Pfizer, Bristol-Myers May Lead $9B Stroke Market
Bloomberg
Mon, 08/29/11 - 10:56 am
stroke
bloodthinners
Pfizer
Eliquis
Bristol-Myers Squibb
ELIQUIS® (apixaban) was Superior to Warfarin for the Reduction of Stroke or Systemic Embolism with Significantly Less Major Bleeding in Patients with Atrial Fibrillation in Phase 3 ARISTOTLE Trial
Yahoo/BusinessWire
Sun, 08/28/11 - 12:22 pm
Eliquis
Apixaban
Warfarin
atrial fibrillation
stroke
Bristol-Myers Squibb
Pfizer
ARISTOTLE trial
Next big drug against cholesterol takes shape
HealthNews
Sat, 08/27/11 - 01:35 pm
Regeneron
Sanofi
hypercholesterolemia
PCSK9
Amgen
Merck
Alnylam
Bristol-Myers Squibb
REGN727

Pages